BackSigilon Therapeutics Overview

Sigilon Therapeutics Selling, General & Admin

Selling, General & Admin expenses for SGTX.

Quarterly SG&A Expenses

$5.88M
↑ 16.7% YoY

As of Jun 30, 2023

Annual SG&A Expenses (TTM)

$19.12M
↓ 2.95% YoY

Trailing 12 months ending Jun 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin